openPR Logo
Press release

Global Nuclear Medicine/Radiopharmaceuticals Market expected to surpass more than US$ 4.0 billion by 2020

05-27-2016 08:40 PM CET | Health & Medicine

Press release from: Market Research Engine

Global Nuclear Medicine/Radiopharmaceuticals Market

Global Nuclear Medicine/Radiopharmaceuticals Market

New York, May 26: Market Research Engine has published a new report titled as “Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2020”

Nuclear medicine is special category in medical branch used for diagnosis and treatment of disease in a safe and painless way. Nuclear medicine contain radioactive material which combined called as radiopharmaceutical. The small quantity of radiopharmaceutical is given into human body in the form of injection or swallowing. It goes to specific location of a body where there could be disease or abnormality. It emits radiation called gamma rays and contains gamma camera which helps nuclear medicine physician to see inside the body. It takes pictures of inner body which helps physician to diagnose patients’ disease.

Browse Full Report: http://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

The nuclear medicine market is expected to exceed more than US$ 4.0 billion by 2020 growing at around 9.0% CAGR for the given forecast period. The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and global Good Manufacturing Practice guidelines. One of the major restraint is that most of the hospital still rely on conventional diagnostic procedures and not able to shift to nuclear medicine due to cost and availability issues. The life of radiopharmaceuticals is small so that sometimes the use of this is restricted.

This report provides:

1) An overview of the global market for nuclear medicine and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for nuclear medicine.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine with the reasons given for variations in the growth of the industry in certain regions.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Nuclear Medicine Market has been segmented as below:

By Procedural Volume Segment Analysis

Diagnostics

SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutics
Beta Emitters
Alpha Emitters
Brachytherapy Isotopes

By Type Analysis

Diagnostics
SPECT Radiopharmaceuticals
Tc-99
Tl-201
Ga-67
I-123
PET Radiopharmaceuticals
F-18
Ru-82
Others

Therapeutics

Beta Emitters
I-131
Sm-153
Rh-186
Y-90
Lu-177
Others
Alpha Emitters
Ra-223
Brachytherapy Isotopes
I-125
Ir-192
Pa-103
Cs-131
Others

By Application Analysis

• Diagnostics
• SPECT
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Others
• PET
• Oncology
• Cardiology
• Neurology
• Others
• Therapeutics
• Thyroid
• Bone Metastasis
• Lymphoma
• Endocrine Tumors
• Others

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: http://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Nuclear Medicine/Radiopharmaceuticals Market expected to surpass more than US$ 4.0 billion by 2020 here

News-ID: 342571 • Views:

More Releases from Market Research Engine

Automotive Lubricants Market 2020 Growth Opportunities, Revenue, Industry Analys …
New York, January 24, 2020: The automotive lubricants market is expected to exceed more than 598 million Gallons by 2024; Growing at a CAGR of more than 8% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BP plc, Chevron Corporation, ExxonMobil Corporation, ConocoPhillips Corporation, Fuchs
Contrast Media Injectors Market is expected to grow more than US$ 1.77 Billion By 2025
Contrast Media Injectors Market is expected to grow more than US$ 1.77 Billion B …
Market Research Engine has recently revealed their new study on how the market of contrast media injectors is blooming because of high demand for imaging products like MRI scans and CT scans. The report focuses mainly on the Global market for contrast media injectors, driving factors that lead to higher market share and restraining factors that restrain the growth. The report is titled - Contrast Media Injectors Market By Product
Drug Delivery Technology Market will Grow at a CAGR of 7.5% Globally by 2021
Drug Delivery Technology Market will Grow at a CAGR of 7.5% Globally by 2021
The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery,transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery andimplantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi

More Releases for Radiopharmaceuticals

Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842 This latest report researches the industry structure, sales, revenue, price and
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a